Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness of Oral Prednisone in Improving Physical Functioning and Decreasing Pain in People With Sciatica

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Seeks care at a Kaiser Permanente clinic spine care specialist at the San Jose, Redwood City, or Roseville site~* Complains of low back pain and functionally incapacitating leg pain extending below the knee with a nerve root distribution~* Score of at least 20 on the modified Oswestry Disability Index~* Appears, in the opinion of the study physician, to be very likely to have a herniated lumbar disc~* MRI study confirms a herniated disc consistent with the signs and symptoms~Exclusion Criteria:~* Onset of sciatica symptoms occurred more than 3 months before study entry~* Cauda equina syndrome~* Active cancer~* Acute spinal fracture~* Currently taking oral steroids~* Diabetes mellitus and taking insulin or glycohemoglobin greater than 10%~* Systolic blood pressure greater than 180 mm Hg or diastolic blood pressure greater than 110 mm Hg~* Pregnant or breastfeeding~* Active peptic ulcer disease~* History of intolerance to steroid therapy~* Bleeding diathesis or anticoagulant therapy~* Ongoing litigation or workers compensation claim for low back pain or sciatica~* Underwent previous lumbar surgery~* Received epidural steroid injection (ESI) within the 12 months before study entry~* Unable to read or speak English~* Progressive or severe motor loss

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Prednisone (Type: EXPERIMENTAL): Participants will receive a 15-day tapering course of prednisone capsules.
- Placebo (Type: PLACEBO_COMPARATOR): Participants will receive a 15-day course of placebo capsules.

Based on this trial design, predict the completion outcome and termination type (if applicable).